Table 1 Basic population details and perinatal factors influencing RDS severity
From: Estimation of early life endogenous surfactant pool and CPAP failure in preterm neonates with RDS
Patients | Whole population (125) | CPAP success (85) | CPAP failure (40) | p |
|---|---|---|---|---|
Gestational age (weeks) | 31.6 (3.3) | 32.9 (2.4) | 29.3 (3.2) | < 0.0001 |
Birth weight (grams) | 1641 (648) | 1807 (593) | 1327 (641) | < 0.0001 |
Complete antenatal steroids | 89 (71%) | 56 (66%) | 24 (60%) | 0.09 |
Clinical chorioamnionitis | 7 (11%) | 3 (3.5%) | 4 (10%) | 0.211 |
Gestational diabetes | 2 (1.6%) | 2 (2.3%) | 0 | 0.999 |
Obstetric cholestasis | 8 (6%) | 6 (7%) | 2 (5%) | 0.962 |
Pre-eclampsia | 21 (17%) | 17 (20%) | 4 (10%) | 0.155 |
Premature rupture of membranes | 10 (8%) | 8 (9.4%) | 2 (5%) | 0.500 |
Caesarean section | 71 (57%) | 67 (79%) | 33 (82%) | 0.811 |
5′ Apgar score | 8.9 (1.3) | 8.9 (1.1) | 8.8 (1.7) | 0.529 |
SGA neonates | 18 (14%) | 13 (15%) | 5 (12%) | 0.660 |